This product is a sulfonylurea pyridine diuretic, which acts on the thick ascending limb of the loop of Henle, inhibits the Na/K/2Cl- carrier system, and increases the excretion of Na, K, Cl- and water in the urine, but has no significant effect on the glomerular filtration rate, renal plasma flow or acid-base balance in the body.

This product is a sulfonylurea pyridine diuretic, which acts on the thick ascending limb of the loop of Henle, inhibits the Na/K/2Cl- carrier system, and increases the excretion of Na, K, Cl- and water in the urine, but has no significant effect on the glomerular filtration rate, renal plasma flow or acid-base balance in the body.

This product is a sulfonylurea pyridine diuretic, which acts on the thick ascending limb of the loop of Henle, inhibits the Na/K/2Cl- carrier system, and increases the excretion of Na, K, Cl- and water in the urine, but has no significant effect on the glomerular filtration rate, renal plasma flow or acid-base balance in the body.

Competitive M cholinergic receptor blocker, used to relieve symptoms of frequent urination, urgency and urgency incontinence caused by overactive bladder. It has high selectivity for M cholinergic receptors, and has very weak effects or affinity on receptors of other neurotransmitters and potential cell targets. After oral administration, it is metabolized by the liver into the active metabolite 5-hydroxymethyl derivative, which has the main pharmacological effect, and its anticholinergic activity is similar to that of this product.

It achieves its antibacterial effect by inhibiting the activity of bacterial DNA gyrase and hindering bacterial replication. It has good antibacterial effects on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, etc., but has poor effects on anaerobic bacteria and enterococci.